Arvee Laboratories (India)- HY1-FY21 PAT dips at Rs. 71.31 lacs against Rs.1.26 crore in HY1-FY20

Arvee Laboratories (India)– HY1-FY21 revenue at Rs.18.68 crore against Rs. 26.98 crore in HY1-FY20

Arvee Laboratories (India) to migrate to NSE Main Board

Arvee Laboratories (India) got the approval from its Board to shift the company listing from the NSE EMERGE platform to NSE main board.

Arvee Laboratories (India) to issue bonus shares in 1:1 ratio

Board at Arvee Laboratories (India) approved the increase in authorised share capital of the company and considered issuing bonus shares to the shareholders.

Rs.96.19 lacs HY2 Standalone PAT at Arvee Laboratories in FY19-20

Arvee Laboratories announced its standalone financial results for the half year ended on March 31, 2020 marking a decline in revenue and PAT margins.

HY1 Profit reached to Rs.1.26 crore at Arvee Laboratories (India) in FY19-20

Arvee Laboratories (India) announced the standalone financial results for half year ended September 30, 2019 marking a decline in profit in spite of rise in revenue as compared to previous HY period.

Double Net in FY2018-19 at Arvee Laboratories

Revenue reached Rs.55.25 Crore at Arvee Laboratories (India) in FY2018-19 against last fiscal year‘s Rs.46.37 Crore.